(MENAFN- EIN Presswire)
mRNA Therapeutics Global market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033
The Business Research Company's mRNA Therapeutics Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033
You Can Now Pre Order Your Report To Get A Swift Deliver With All Your Needs” - The Business Research company
LONDON, GREATER LONDON, UNITED KINGDOM, September 9, 2024 /EINPresswire / -- The mRNA therapeutics market has experienced robust growth in recent years, expanding from $33.50 billion in 2023 to $34.76 billion in 2024 at a compound annual growth rate (CAGR) of 3.8%. The growth in the historic period can be attributed to increasing financial support for the creation of efficient pharmaceuticals and vaccines, the expansion of federal programs dedicated to advancing RNA-based medicines heightened awareness regarding rare genetic diseases, and a rise in the number of clinical trials.
What Is The Estimated Market Size Of The Global mRNA Therapeutics Market And Its Annual Growth Rate?
The mRNA therapeutics market is projected to continue its strong growth, reaching $40.69 billion in 2028 at a compound annual growth rate (CAGR) of 4.0%. The growth in the forecast period can be attributed to the growing number of infectious diseases, the increasing number of patients visiting hospitals and clinics, expanding applications of mRNA therapeutics, growing demand for personalized and precision medicine, favourable regulatory environments, and accelerated approval pathways.
Explore Comprehensive Insights Into The Global mRNA Therapeutics Market With A Detailed Sample Report:
Growth Driver Of The mRNA Therapeutics Market
The increased prevalence of long-lasting and communicable diseases is expected to propel the growth of the mRNA therapeutics market going forward. Long-lasting and communicable diseases are illnesses that persist for extended periods and can be transmitted between individuals, such as tuberculosis, HIV/AIDS, and hepatitis. The prevalence of long-lasting and communicable diseases is increasing due to increased global travel and inadequate healthcare infrastructure, which facilitate the spread and hinder the effective management of these illnesses. mRNA therapeutics are useful for long-lasting and communicable diseases by rapidly enabling the body to produce proteins that boost immune responses, leading to quicker development of vaccines and treatments.
Order Your Report Now For A Swift Delivery:
Which Market Players Are Steering The mRNA Therapeutics Market Growth?
Key players in the mRNA therapeutics market include Pfizer Inc., Novartis AG, Sanofi AG, AstraZeneca plc, GlaxoSmithKline plc, Hoffmann-La Roche AG, Moderna Therapeutics Inc, BioNTech SE.
What Are The Key Trends That Influence mRNA Therapeutics Market Share And Analysis?
Major companies operating in the mRNA therapeutics market are focusing on developing innovative solutions, such as mRNA-based booster vaccines, to enhance immunity against evolving viral variants. An mRNA-based booster vaccine refers to a vaccine that uses messenger RNA (mRNA) technology to enhance and prolong immunity against a specific pathogen, often after the initial vaccination series.
How Is The Global mRNA Therapeutics Market Segmented?
1) By Product: Vaccines, Drugs
2) By Application: Infectious Diseases, Oncology, Rare Genetic Diseases, Respiratory Diseases, Other Applications
3) By End Use: Hospitals And Clinics, Research Organizations, Other End Uses
Geographical Insights: North America Leading The mRNA Therapeutics Market
North America was the largest region in the mRNA therapeutics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mRNA therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
mRNA Therapeutics Market Definition
Messenger RNA (mRNA) therapeutics refers to a type of medical treatment that utilizes messenger RNA (mRNA) molecules to produce therapeutic proteins within the body. These therapeutics are used to prevent, treat, or cure diseases by directing cells to produce specific proteins that are needed for therapeutic effects.
mRNA Therapeutics Global Market Report 2024 from TBRC covers the following information:
.Market size data for the forecast period: Historical and Future
.Macroeconomic factors affecting the market in the short and long run
.Analysis of the macro and micro economic factors that have affected the market in the past five years
.Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
.Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
An overview of the global mRNA therapeutics market report covering trends, opportunities, strategies, and more
The mRNA Therapeutics Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on mRNA therapeutics market size, mRNA therapeutics market drivers and trends , mRNA therapeutics market major players, mRNA therapeutics competitors' revenues, mRNA therapeutics market positioning, and mRNA therapeutics market growth across geographies. The mRNA therapeutics market report helps you gain in-depth insights into opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.
Browse Through More Similar Reports By The Business Research Company:
mRNA Cancer Vaccines And Therapeutics Global Market Report 2024
report/mrna-cancer-vaccines-and-therapeutics-global-market-report
Bipolar Disorder Therapeutics Global Market Report 2024
report/bipolar-disorder-therapeutics-global-market-report
Peptide Therapeutics Global Market Report 2024
report/peptide-therapeutics-global-market-report
What Does The Business Research Company Do?
The Business Research Company publishes over 15,000 reports across 27 industries and 60+ geographies. Our research is powered by 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. We provide continuous and custom research services, offering a range of specialized packages tailored to your needs, including Market Entry Research Package, Competitor Tracking Package, Supplier & Distributor Package, and much more.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
...
Visit us on social media:
Facebook
X
LinkedIn
Hydrolyzed Vegetable Proteins Market Insights, Growth Drivers, and Culinary Innovations!
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
MENAFN09092024003118003196ID1108652869